Ultrasound Findings in Diabetic Pregnancies - Trial NCT06407388
Access comprehensive clinical trial information for NCT06407388 through Pure Global AI's free database. This phase not specified trial is sponsored by Eastern Virginia Medical School and is currently Recruiting. The study focuses on Diabetes. Target enrollment is 156 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Eastern Virginia Medical School
Timeline & Enrollment
N/A
Jun 01, 2023
Jun 01, 2025
Primary Outcome
Elevated TcB
Summary
The goal of our study is to identify ultrasonographic markers that can predict adverse
 neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will
 increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring
 phototherapy. This information can be used in patient counseling and to guide future
 screening protocols for ultrasound in individuals with diabetes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06407388
Non-Device Trial